OIM

Oracle Investment Management Portfolio holdings

AUM $153M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+42.86%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$153M
AUM Growth
+$9.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
24
New
Increased
Reduced
Closed

Top Buys

1 +$2.05M
2 +$1.29M
3 +$961K
4
DAWN icon
Day One Biopharmaceuticals
DAWN
+$835K
5
EWTX icon
Edgewise Therapeutics
EWTX
+$770K

Top Sells

1 +$5.38M
2 +$3.94M
3 +$2.75M
4
NVAX icon
Novavax
NVAX
+$2.11M
5
WGS icon
GeneDx Holdings
WGS
+$727K

Sector Composition

1 Healthcare 98.77%
2 Consumer Discretionary 0.8%
3 Industrials 0.05%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WGS icon
1
GeneDx Holdings
WGS
$2.28B
$115M 75.4%
884,654
-5,300
ARDX icon
2
Ardelyx
ARDX
$1.42B
$10.9M 7.15%
1,872,624
+368,798
BHVN icon
3
Biohaven
BHVN
$1.44B
$8.72M 5.71%
772,181
+32,195
QDEL icon
4
QuidelOrtho
QDEL
$1.16B
$3.38M 2.21%
118,291
FORA icon
5
Forian
FORA
$63.7M
$2.9M 1.9%
1,366,107
PSNL icon
6
Personalis
PSNL
$703M
$2.7M 1.77%
339,343
+109,908
TDOC icon
7
Teladoc Health
TDOC
$958M
$2.48M 1.63%
354,338
-351,078
TSHA icon
8
Taysha Gene Therapies
TSHA
$1.23B
$1.46M 0.96%
+265,000
CAVA icon
9
CAVA Group
CAVA
$9.54B
$1M 0.66%
17,100
EWTX icon
10
Edgewise Therapeutics
EWTX
$3.17B
$951K 0.62%
+38,343
DAWN icon
11
Day One Biopharmaceuticals
DAWN
$2.2B
$932K 0.61%
+100,000
ARKG icon
12
ARK Genomic Revolution ETF
ARKG
$1.06B
$565K 0.37%
+19,500
SGMO icon
13
Sangamo Therapeutics
SGMO
$141M
$435K 0.29%
1,035,742
+31,018
BIIB icon
14
Biogen
BIIB
$26.6B
$424K 0.28%
2,412
TEM
15
Tempus AI
TEM
$8.94B
$384K 0.25%
+6,507
TSLA icon
16
Tesla
TSLA
$1.47T
$225K 0.15%
500
HTZ icon
17
Hertz
HTZ
$1.22B
$77.1K 0.05%
+15,000
KOID
18
KraneShares Global Humanoid and Embodied Intelligence Index ETF
KOID
$124M
-22,400
PLTR icon
19
Palantir
PLTR
$361B
-29,500
PFE icon
20
Pfizer
PFE
$151B
0
NVAX icon
21
Novavax
NVAX
$1.67B
-243,000
CNC icon
22
Centene
CNC
$16.9B
-110,300
BDSX icon
23
Biodesix
BDSX
$176M
-15,000